The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

A CRITIQUE OF PSYCHIATRIC AND PSYCHOLOGICAL RESEARCH ON INSULIN TREATMENT IN SCHIZOPHRENIA

Published Online:https://doi.org/10.1176/ajp.110.10.774

After twenty years of research with insulin treatment in schizophrenia the published evidence is inconclusive and contradictory. Wide variations in remission and recovery have been reported but the number of published control studies is meagre. Psychological tests yield no definitive data on prognosis or the effects of treatment. Insulin treatment in schizophrenia continues to pose a major challenge to research.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.